Neuroone Historical Balance Sheet

NMTC Stock

USD 1.08 0.06 5.26%

Trend analysis of Neuroone Medical Technologies balance sheet accounts such as Other Current Liab of 1.4 M provides information on Neuroone Medical's total assets, liabilities, and equity, which is the actual value of Neuroone Medical Tec to its prevalent stockholders. By breaking down trends over time using Neuroone Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Neuroone Medical Tec latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Neuroone Medical Tec is a good buy for the upcoming year.

Neuroone Medical Inventory

3.18 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuroone Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Neuroone Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Neuroone Medical Tec at a specified time, usually calculated after every quarter, six months, or one year. Neuroone Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Neuroone Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Neuroone currently owns. An asset can also be divided into two categories, current and non-current.

Neuroone Medical Balance Sheet Chart

At present, Neuroone Medical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 400.8 K, whereas Net Debt is forecasted to decline to (1.1 M).

Common Stock Shares Outstanding Short Long Term Debt Total Other Current Liab Total Liab

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most accounts from Neuroone Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Neuroone Medical Tec current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuroone Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	184.4K	260.2K	299.2K	400.8K
Total Assets	8.1M	5.4M	6.2M	6.5M

Short Long Term Debt Total Total Assets

Neuroone Medical balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Total Equity	Non Current Liabilities Total	Total Liab	Total Current Assets	Common Stock	Other Stockholder Equity	Short Term Debt	Current Deferred Revenue	Accounts Payable	Other Liab	Net Tangible Assets	Intangible Assets	Net Invested Capital	Net Working Capital	Capital Stock	Property Plant And Equipment Net
Common Stock Shares Outstanding		0.69	-0.14	0.73	0.55	0.37	-0.35	-0.93	0.37	0.36	0.84	0.78	0.75	0.57	0.93	0.96	-0.26	-0.18	0.8	0.4	0.91	-0.55	0.48	0.66	0.78	0.87
Total Assets	0.69		-0.08	0.51	0.6	0.86	-0.89	-0.83	0.92	0.92	0.86	0.25	0.52	0.98	0.65	0.83	-0.19	0.21	0.68	0.51	0.84	-0.32	0.95	0.99	0.7	0.86
Short Long Term Debt Total	-0.14	-0.08		0.53	0.67	-0.41	0.24	0.03	-0.04	-0.06	0.11	0.29	0.51	-0.1	0.08	-0.07	0.98	0.55	0.24	0.41	-0.29	0.67	-0.04	-0.04	-0.03	-0.08
Other Current Liab	0.73	0.51	0.53		0.9	0.03	-0.12	-0.74	0.27	0.25	0.71	0.81	0.95	0.41	0.76	0.73	0.44	0.28	0.74	0.65	0.54	0.01	0.35	0.5	0.6	0.66
Total Current Liabilities	0.55	0.6	0.67	0.9		0.15	-0.26	-0.64	0.44	0.46	0.7	0.63	0.92	0.53	0.64	0.62	0.59	0.57	0.72	0.67	0.43	0.18	0.5	0.58	0.46	0.58
Total Stockholder Equity	0.37	0.86	-0.41	0.03	0.15		-0.98	-0.55	0.92	0.92	0.59	-0.21	0.02	0.89	0.29	0.54	-0.47	0.04	0.35	0.22	0.66	-0.37	0.92	0.86	0.48	0.62
Net Debt	-0.35	-0.89	0.24	-0.12	-0.26	-0.98		0.56	-0.97	-0.96	-0.64	0.18	-0.09	-0.92	-0.3	-0.55	0.31	-0.13	-0.41	-0.34	-0.63	0.25	-0.96	-0.9	-0.53	-0.64
Retained Earnings	-0.93	-0.83	0.03	-0.74	-0.64	-0.55	0.56		-0.6	-0.57	-0.95	-0.65	-0.73	-0.75	-0.93	-0.99	0.16	0.1	-0.86	-0.53	-0.93	0.47	-0.7	-0.84	-0.87	-0.97
Cash	0.37	0.92	-0.04	0.27	0.44	0.92	-0.97	-0.6		0.98	0.7	-0.09	0.25	0.94	0.37	0.58	-0.11	0.26	0.46	0.44	0.62	-0.14	0.99	0.93	0.57	0.68
Cash And Short Term Investments	0.36	0.92	-0.06	0.25	0.46	0.92	-0.96	-0.57	0.98		0.66	-0.09	0.26	0.95	0.33	0.55	-0.12	0.36	0.45	0.4	0.6	-0.14	0.97	0.92	0.48	0.63
Common Stock Total Equity	0.84	0.86	0.11	0.71	0.7	0.59	-0.64	-0.95	0.7	0.66		0.59	0.72	0.78	0.9	0.95	-0.04	-0.04	0.9	0.58	0.87	-0.31	0.77	0.88	0.88	0.94
Non Current Liabilities Total	0.78	0.25	0.29	0.81	0.63	-0.21	0.18	-0.65	-0.09	-0.09	0.59		0.86	0.11	0.79	0.68	0.17	-0.07	0.73	0.45	0.5	-0.17	0.01	0.23	0.56	0.52
Total Liab	0.75	0.52	0.51	0.95	0.92	0.02	-0.09	-0.73	0.25	0.26	0.72	0.86		0.41	0.79	0.73	0.41	0.32	0.76	0.62	0.54	-0.01	0.33	0.49	0.58	0.65
Total Current Assets	0.57	0.98	-0.1	0.41	0.53	0.89	-0.92	-0.75	0.94	0.95	0.78	0.11	0.41		0.52	0.73	-0.18	0.26	0.59	0.48	0.76	-0.31	0.97	0.97	0.65	0.81
Common Stock	0.93	0.65	0.08	0.76	0.64	0.29	-0.3	-0.93	0.37	0.33	0.9	0.79	0.79	0.52		0.94	-0.06	-0.19	0.89	0.43	0.86	-0.43	0.48	0.65	0.79	0.88
Other Stockholder Equity	0.96	0.83	-0.07	0.73	0.62	0.54	-0.55	-0.99	0.58	0.55	0.95	0.68	0.73	0.73	0.94		-0.21	-0.12	0.86	0.5	0.95	-0.48	0.67	0.82	0.85	0.95
Short Term Debt	-0.26	-0.19	0.98	0.44	0.59	-0.47	0.31	0.16	-0.11	-0.12	-0.04	0.17	0.41	-0.18	-0.06	-0.21		0.6	0.08	0.33	-0.42	0.71	-0.13	-0.15	-0.16	-0.2
Current Deferred Revenue	-0.18	0.21	0.55	0.28	0.57	0.04	-0.13	0.1	0.26	0.36	-0.04	-0.07	0.32	0.26	-0.19	-0.12	0.6		-0.02	0.2	-0.17	0.45	0.23	0.15	-0.27	-0.11
Accounts Payable	0.8	0.68	0.24	0.74	0.72	0.35	-0.41	-0.86	0.46	0.45	0.9	0.73	0.76	0.59	0.89	0.86	0.08	-0.02		0.58	0.74	-0.21	0.57	0.71	0.72	0.77
Other Liab	0.4	0.51	0.41	0.65	0.67	0.22	-0.34	-0.53	0.44	0.4	0.58	0.45	0.62	0.48	0.43	0.5	0.33	0.2	0.58		0.25	0.33	0.45	0.51	0.5	0.51
Net Tangible Assets	0.91	0.84	-0.29	0.54	0.43	0.66	-0.63	-0.93	0.62	0.6	0.87	0.5	0.54	0.76	0.86	0.95	-0.42	-0.17	0.74	0.25		-0.65	0.71	0.83	0.8	0.92
Intangible Assets	-0.55	-0.32	0.67	0.01	0.18	-0.37	0.25	0.47	-0.14	-0.14	-0.31	-0.17	-0.01	-0.31	-0.43	-0.48	0.71	0.45	-0.21	0.33	-0.65		-0.22	-0.31	-0.41	-0.5
Net Invested Capital	0.48	0.95	-0.04	0.35	0.5	0.92	-0.96	-0.7	0.99	0.97	0.77	0.01	0.33	0.97	0.48	0.67	-0.13	0.23	0.57	0.45	0.71	-0.22		0.97	0.62	0.76
Net Working Capital	0.66	0.99	-0.04	0.5	0.58	0.86	-0.9	-0.84	0.93	0.92	0.88	0.23	0.49	0.97	0.65	0.82	-0.15	0.15	0.71	0.51	0.83	-0.31	0.97		0.75	0.87
Capital Stock	0.78	0.7	-0.03	0.6	0.46	0.48	-0.53	-0.87	0.57	0.48	0.88	0.56	0.58	0.65	0.79	0.85	-0.16	-0.27	0.72	0.5	0.8	-0.41	0.62	0.75		0.9
Property Plant And Equipment Net	0.87	0.86	-0.08	0.66	0.58	0.62	-0.64	-0.97	0.68	0.63	0.94	0.52	0.65	0.81	0.88	0.95	-0.2	-0.11	0.77	0.51	0.92	-0.5	0.76	0.87	0.9

Click cells to compare fundamentals

Neuroone Medical Account Relationship Matchups

Neuroone Medical balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	10.7M	16.0M	18.1M	26.8M	30.8M	32.3M
Total Assets	7.9M	12.8M	8.1M	5.4M	6.2M	6.5M
Short Long Term Debt Total	315.7K	202.9K	184.4K	260.2K	299.2K	400.8K
Other Current Liab	531.5K	632.5K	978.4K	1.1M	1.3M	1.4M
Total Current Liabilities	1.2M	3.1M	1.8M	2.2M	2.5M	2.7M
Total Stockholder Equity	6.6M	9.6M	6.2M	822.0K	945.3K	1.5M
Net Debt	(6.6M)	(8.0M)	(5.1M)	(1.2M)	(1.1M)	(1.1M)
Retained Earnings	(40.8M)	(50.8M)	(62.7M)	(75.0M)	(67.5M)	(64.1M)
Cash	6.9M	8.2M	5.3M	1.5M	1.7M	2.0M
Cash And Short Term Investments	6.9M	11.1M	5.3M	1.5M	1.7M	2.3M
Liabilities And Stockholders Equity	7.9M	12.8M	8.1M	5.4M	6.2M	6.5M
Non Current Liabilities Total	202.9K	119.6K	55.3K	2.3M	2.7M	2.8M
Total Liab	1.4M	3.2M	1.8M	4.5M	5.2M	5.5M
Total Current Assets	7.3M	12.2M	7.3M	4.6M	5.3M	2.7M
Common Stock	12.0K	16.2K	23.9K	30.8K	35.4K	37.2K
Other Stockholder Equity	47.4M	60.4M	68.9M	75.8M	87.2M	91.5M
Short Term Debt	112.8K	83.3K	129.1K	65.8K	75.6K	71.9K
Accounts Payable	528.8K	927.7K	685.1K	1.0M	1.2M	1.2M
Net Tangible Assets	(1.4M)	1.9M	6.4M	9.5M	10.9M	11.5M
Non Current Assets Total	646.5K	646.8K	784.4K	739.0K	849.9K	445.5K
Capital Lease Obligations	315.7K	202.9K	55.3K	260.2K	299.2K	314.1K
Inventory	98.3K	704.5K	1.7M	2.6M	3.0M	3.2M
Other Current Assets	244.0K	296.6K	263.7K	359.1K	413.0K	433.6K
Property Plant And Equipment Gross	602.3K	721.3K	694.8K	1.2M	1.4M	1.5M
Intangible Assets	134.2K	111.9K	89.6K	67.3K	60.5K	113.3K
Property Plant Equipment	52.0K	448.2K	512.3K	535.0K	615.2K	646.0K
Net Invested Capital	6.6M	9.6M	6.2M	822.0K	945.3K	898.0K
Net Working Capital	6.1M	9.1M	5.5M	2.4M	2.8M	2.2M
Capital Stock	35.8K	16.2K	23.9K	30.8K	35.4K	23.9K
Property Plant And Equipment Net	512.3K	535.0K	694.8K	671.8K	772.5K	534.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

When determining whether Neuroone Medical Tec offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neuroone Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neuroone Medical Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neuroone Medical Technologies Stock:

How To Invest In Neuroone

Details

Is Neuroone Stock a good investment?

Details

What is Neuroone Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuroone Medical. If investors know Neuroone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuroone Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.46)

Revenue Per Share

0.158

Quarterly Revenue Growth

0.311

Return On Assets

(1.43)

Return On Equity

(3.49)

The market value of Neuroone Medical Tec is measured differently than its book value, which is the value of Neuroone that is recorded on the company's balance sheet. Investors also form their own opinion of Neuroone Medical's value that differs from its market value or its book value, called intrinsic value, which is Neuroone Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuroone Medical's market value can be influenced by many factors that don't directly affect Neuroone Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Neuroone Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuroone Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuroone Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Neuroone Historical Balance Sheet

Neuroone Medical Inventory

3.18 Million

About Neuroone Balance Sheet Analysis

Neuroone Medical Balance Sheet Chart

Common Stock Shares Outstanding

Total Liab

Neuroone Medical balance sheet Correlations

Neuroone Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Neuroone Medical balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Working Capital	+ 0.99	Total Assets
Net Invested Capital	+ 0.99	Cash
Total Current Assets	+ 0.98	Total Assets
Short Term Debt	+ 0.98	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.98	Cash
Net Invested Capital	+ 0.97	Cash And Short Term Investments

Other Stockholder Equity	- 0.99	Retained Earnings
Net Debt	- 0.98	Total Stockholder Equity
Property Plant And Equipment Net	- 0.97	Retained Earnings
Cash	- 0.97	Net Debt
Net Invested Capital	- 0.96	Net Debt
Cash And Short Term Investments	- 0.96	Net Debt